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Abstract
Background: There has been concern that the incidence of autism and other pervasive
developmental disorders (PDDs) is increasing. Previous studies have been smaller, restricted to
autism (excluding other pervasive developmental disorders such as Asperger's syndrome), included
boys only, or have not been based on a national sample. We investigated time trends in the rates
of diagnosis of pervasive developmental disorders.
Methods: We analysed the rates of first diagnosis of pervasive developmental disorders among
people registered with a practice contributing to the United Kingdom General Practice Research
Database during the period 1988 to 2001. We included 1410 cases from over 14 million person-
years of observation. The main outcome measures were rates of diagnosis of pervasive
developmental disorders by year of diagnosis, year of birth, gender and geographical region.
Results: The rate increased progressively from 0.40/10,000 person-years (95% CI 0.30 to 0.54) in
1991 to 2.98/10,000 (95% CI 2.56 to 3.47) in 2001. A similar change occurred in the age
standardised incidence ratios, from 35 (95% CI: 26–47) in 1991 to 365 (95% CI: 314–425) in 2001.
The temporal increase was not limited to children born during specific years nor to children
diagnosed in a specific time period. The rate of diagnosis of PDDs other than autism rose from zero
for the period 1988–1992 to 1.06/10,000 person-years in 2001. The rate of diagnosis of autism also
increased but to a lesser extent. There was marked geographical variation in rates, with
standardised incidence ratios varying from 66 for Wales to 141 for the South East of England.
Conclusions: Better ascertainment of diagnosis is likely to have contributed to the observed
temporal increase in rates of diagnosis of PDD, but we cannot exclude a real increase.
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Background
The term pervasive developmental disorder (PDD) refers
to a range of disorders with onset in childhood character-
ised by abnormalities in the domains of language devel-
opment, communication abilities and social interactions
and by a rigid, repetitive pattern of behaviours and inter-
ests [1]. Within PDDs, autism refers to children meeting
full diagnostic criteria for the above three domains of
developmental impairments and onset before the age of
three years. The other PDDs are Asperger's syndrome (a
less severe form of PDD with the features described above
but without language delay and with intelligence within
the normal range), pervasive developmental disorder not
otherwise specified (not fulfilling complete criteria for
autism), and childhood disintegrative disorder (a severe
form of autism developing in previously normal children
who undergo massive regression between the ages of 2
and 10 years) [2]. Rett's disorder (occurring only in girls,
characterised by acquired microcephaly, regression and
neurological signs) is also classified as a PDD in ICD-10
but has a known genetic aetiology [3] and is not included
in the incidence estimates presented in this paper.
There have been a number of reports that the incidence of
PDD is increasing [3] and the prevalence for all PDDs
appears to be around the 60/10,000 in recent studies in
the United Kingdom [4] and the United States [5]. There
is some evidence that increased prevalence rates are due to
a broadening of the concept of PDD and changes in diag-
nostic practice [6,7]. This has not gone unchallenged,
however, and it is likely that increased awareness and
changes in educational and social policies account for
some of the recent upward trend in rates[6,8]. However, a
real increase in the incidence cannot be ruled out [3].
As part of a case-control study to identify risk factors for
autism and other PDDs [9], we have investigated time
trends in the incidence of the diagnosis of PDDs using
data obtained from the United Kingdom General Practice
Research Database (GPRD).
Methods
The General Practice Research Database
The GPRD was set up in 1987, then known as the VAMP
(Value Added Medical Products) Research Bank [10]. It
consists of the electronic clinical records of patients regis-
tered with contributing general practices and aims to
include complete prescribing and diagnostic information.
The practices included in the GPRD are broadly represent-
ative of all practices in England and Wales in terms of geo-
graphical distribution, practice sizes and the age and
gender distributions of registered patients [11]. Contrib-
uting practices must meet a range of data quality criteria
before they are included in the GPRD. The quality of the
information in the database, including the completeness
of recording of diagnoses made in medical facilities out-
side the practice, has been validated in a number of inde-
pendent studies and has been found to be high [10]. There
is excellent agreement between prescribing data from the
GPRD and national data from the Prescription Pricing
Authority [12]. General practices contributing to the
GPRD originally used a software system called VAMP but
during the late 1990s most practices switched to a new
software system called VISION. At the start of the study
period, general practitioners contributing to the GPRD
used a modified version of the Oxford Medical Informa-
tion Systems coding system (OXMIS) to record diagnoses
[13], but in later years most practices used the READ cod-
ing system [14].
Each individual is assigned a unique identification
number and all data that could identify individuals are
removed from records before they are incorporated into
the GPRD.
Study population and denominators
The information analysed in the present study comprised
the electronic medical records of children born in 1973 or
later and registered with general practices contributing
data to the GPRD during the period 1st January 1988 to
the 31st December 2001. Such children will have been eli-
gible at some time in their life for MMR vaccination, an
exposure of particular interest in the case-control study
[9].
For a specific general practice, the start of the observation
period for this study was taken as the later of either the 1st
January 1988 or the date at which the practice started con-
tributing data to the GPRD. The end of the observation
period was the date at which the practice stopped contrib-
uting data to the GPRD, or the 31st December 2001 if this
was earlier. Individual patients were included in the study
during the times within the observation period that they
were registered with a practice contributing to the GPRD.
The number of practices included in the GPRD varied dur-
ing the study period, rising from 34 in 1988 to 557 in
1996 then falling to 380 by 2001.
Age- and gender-specific rates were calculated for people
born in 1973 or later and registered with contributing
general practices during each calendar year. Those regis-
tered for part of a particular year contributed time at risk
for the period they were registered. People were classified
by geographical location of their general practice by coun-
try for Wales, Northern Ireland and Scotland, and by the
eight former administrative National Health Service
regions for England.
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Identification of cases
When a patient first registers with a practice contributing
to the GPRD, past medical events and diagnoses judged to
be clinically important by the general practitioner are
recorded in the electronic record, with the date of each
diagnosis where available. While a patient is registered
with a contributing practice, all new diagnoses and all
new drug therapies or changes in existing therapies are
recorded contemporaneously. Cases were defined as peo-
ple born in 1973 or later who had a first diagnosis of PDD
entered into their general practice record while registered
with a practice contributing to the GPRD during the study
period. Cases were identified by searching the complete
medical record of all people registered with participating
practices during the study period for either OXMIS or
READ clinical codes indicating a diagnosis of PDD:
Appendix [see Additional file 1]. People with a diagnosis
of a PDD made prior to their observation period, and peo-
ple whose PDD diagnosis was the first entry recorded
when they joined a practice, were classified as prevalent
cases and were excluded from the incidence estimates.
On the basis of the recorded diagnoses patients were clas-
sified as 'autism' or 'other PDD'. Those with autistic disor-
ders and similar presentations were grouped in the autism
category and other descriptions (such as Asperger's syn-
drome) were grouped in the other PDD category.
Analysis
Crude rates and age standardised incidence ratios for first
diagnosis of all PDDs, autism, and other PDDs were cal-
culated by year of diagnosis and gender and for different
geographical regions. Because of low numbers of cases in
some years, indirect standardisation was used with rates
during the whole study period as the standard rates. The
age-standardised incidence ratios presented take into
account variations in the age structure of the population
in different time periods and different geographical
regions. Rates of first diagnosis were calculated by year of
diagnosis and year of birth, both in two year intervals.
Ethical approval
Ethical approval for the study was obtained from the Sci-
entific and Ethical Advisory Group of the GPRD and from
the ethics committee of the London School of Hygiene
and Tropical Medicine.
Results
We identified 1410 persons with a first recorded diagnosis
of PDD during the study period: 1097 were categorised as
autism and 313 as other PDD, for 294 (94%) of whom the
diagnosis was Asperger's syndrome (appendix).
Table 1 shows the crude rates of first diagnosis of PDD
and age standardised incidence ratios by year of diagnosis
and gender.
The person-years at risk varied from year to year because
of changes in the number of contributing practices, which
increased until the mid 1990s and then fell. During the
study period incidence rates increased progressively for
both males and females. The patterns of crude rates and of
standardised incidence ratios were very similar. The over-
all rate increased seven-fold from 0.40/10,000 person-
years (95% CI 0.30 to 0.54) in 1991 to 2.98/10,000 per-
son-years (95% CI 2.56 to 3.47) in 2001. A similar change
Table 1: First diagnoses of PDD by year of diagnosis and gender
Year Number of cases Person years at risk Crude incidence rate 
(per 10000 person-years)
Male:Female 
incidence 
rate ratio
Age standardised 
incidence ratio (S.I.R)
All M F All M F All M F All M F
1988 1 1 0 94474 49353 45121 0.11 0.20 0 ∞ 8 10 0
1989 6 6 0 260978 135542 125436 0.23 0.44 0 ∞ 19 22 0
1990 21 20 1 643830 332819 311012 0.33 0.60 0.03 18.7 28 32 8
1991 45 36 9 1118577 576722 541855 0.40 0.62 0.17 3.8 35 34 42
1992 45 37 8 1311605 675188 636417 0.34 0.55 0.13 4.3 31 31 33
1993 69 51 18 1376111 707674 668437 0.50 0.72 0.27 2.7 47 42 72
1994 77 61 16 1432528 735395 697134 0.54 0.83 0.23 3.6 52 49 64
1995 108 97 11 1476627 756200 720427 0.73 1.28 0.15 8.4 74 79 45
1996 102 85 17 1381242 705526 675716 0.74 1.21 0.25 4.8 78 78 77
1997 133 115 18 1283151 653791 629359 1.04 1.76 0.29 6.2 114 119 89
1998 192 152 40 1228058 624723 603335 1.56 2.43 0.66 3.7 180 173 218
1999 231 193 38 1121383 568937 552446 2.06 3.39 0.69 4.9 242 244 231
2000 211 179 32 935906 474344 461562 2.26 3.77 0.69 5.4 277 284 244
2001 169 139 30 567058 287574 279483 2.98 4.83 1.07 4.5 365 361 388
All 1410 1172 238 14231526 7283787 6947739 0.99 1.61 0.34 4.8 100 100 100
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occurred in the age standardised incidence ratios, from 35
(95% CI: 26–47) in 1991 to 365 (95% CI: 314–425) in
2001. The overall male to female ratio was 4.8 and during
1991 to 2001 ranged from 2.7 to 8.4 (chi-squared test for
heterogeneity, p = 0.21), with no clear temporal trend.
Table 2 shows the number of cases, person-years of fol-
low-up and rate of first recorded diagnosis by date of diag-
nosis and by date of birth, both in two year intervals. The
diagonally linked numbers identify rates among children
of the same age in different years. The temporal increase
observed in rates of diagnosis is not limited to children
born during specific years or to children diagnosed in a
specific time period. The rates of diagnosis for children at
the same age, born in successive birth cohorts, increased
in each successive cohort, including for relatively old ages
at diagnosis. For example, for diagnoses at the ages of two
to four years, the rates of new diagnosis per 10 000 per-
son-years from 1992–93 to 2000–01 were 1.41, 2.70,
3.07, 5.56 and 7.74. Corresponding rates at ages eight to
ten years were 0.36, 0.40, 0.67, 2.46 and 4.46.
Table 3 shows the rates of first recorded diagnosis and age
standardised incidence ratios of autism and other PDDs
by year of diagnosis.
Table 2: Number of cases, person-years follow-up and rates of first recorded diagnosis of PDD (per 10,000 person-years) by year of 
diagnosis and year of birth (in two year categories). The diagonally linked numbers identify rates among children of the same age in 
different years
Year of first diagnosis
1992–93 1994–95 1996–97 1998–99 2000–01
Birthyear n PY rate n PY rate n PY rate n PY rate n PY rate
73–74 5 257638 0.19 5 263712 0.19 1 233838 0.04 4 194554 0.21 4 118997 0.34 age 26–28
75–76 0 233164 0.00 4 232393 0.17 5 208111 0.24 4 175331 0.23 2 107426 0.19 age 24–26
77–78 5 233093 0.21 2 227191 0.09 7 191785 0.36 8 162057 0.49 0 100419 0.00 age 22–24
79–80 1 265530 0.04 2 257752 0.08 9 211888 0.42 13 171491 0.76 3 104136 0.29 age 20–22
81–82 6 268477 0.22 3 262006 0.11 6 217307 0.28 20 174989 1.14 10 104093 0.96 age 18–20
83–84 10 275918 0.36 9 270128 0.33 4 226897 0.18 12 184013 0.65 5 110565 0.45 age 16–18
85–86 14 283299 0.49 11 277108 0.40 21 231591 0.91 28 187229 1.50 12 112080 1.07 age 14–16
87–88 26 294006 0.88 18 285548 0.63 16 237945 0.67 32 191788 1.67 31 114057 2.72 age 12–14
89–90 42 298297 1.41 45 289890 1.55 30 241271 1.24 48 194806 2.46 41 116246 3.53 age 10–12
91–92 5 248952 0.2 77 285511 2.70 53 238318 2.22 56 192373 2.91 51 114277 4.46 age 8–10
93–94 0 29342 9 231555 0.39 70 227807 3.07 89 184757 4.82 67 110641 6.06 age 6–8
95–96 0 26360 13 177284 0.73 98 176267 5.56 69 106292 6.49 age 4–6
97–98 0 20351 11 144307 0.76 81 104606 7.74 age 2–4
99–00 0 15479 4 79129 0.51 age 0–2
Table 3: Crude rates of first diagnosis (per 10 000 person-years) and age standardised incidence ratios for autism and other PDDs by 
year of diagnosis
year Total cases Cases with 'other
PDD' diagnosis
% cases with 'other
PDD' diagnosis
incidence
other PDDs
incidence
autism
SIR other
PDDs
SIR autism
1988 1 0 0 0 0.11 0 10
1989 6 0 0 0 0.23 0 23
1990 21 0 0 0 0.33 0 35
1991 45 0 0 0 0.40 0 44
1992 45 0 0 0 0.34 0 39
1993 69 2 3 0.01 0.49 6 58
1994 77 2 3 0.01 0.52 6 64
1995 108 3 3 0.02 0.71 9 91
1996 102 8 8 0.06 0.68 27 92
1997 133 18 14 0.14 0.90 67 128
1998 192 51 27 0.42 1.15 204 173
1999 231 87 38 0.78 1.28 369 200
2000 211 82 39 0.88 1.38 435 225
2001 169 60 36 1.06 1.92 495 319
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There was a striking rise in the rate of diagnoses of other
PDDs: from zero for the period 1988 to 1992 rising to
1.06/10,000 person-years by 2001. Over the study period
the rate of diagnosis of autism also increased substan-
tially. The patterns were broadly similar for males and
females (data not shown). Few diagnoses of other PDDs
were made before 1997, but by 2001 over one third of all
diagnoses were PDDs other than autism.
Table 4 shows the rates of first recorded autism and other
PDDs by geographical area.
There was marked geographical variation in rates of first
diagnosis, with the lowest rate in Wales being less than
half the rate in the South East of England (chi-squared test
for heterogeneity in SIRs by region, p < 0.001). In general,
the regional variations were less marked for autism than
for other PDDs and the ratio of the diagnoses of autism
compared with other PDDs varied greatly between areas
(chi-squared test for heterogeneity, p = 0.0006).
Discussion
There was around a 10-fold increase in the rate of first
recorded diagnoses of PDDs in United Kingdom general
practice medical records from 1988–92 to 2000–01 (table
1). The increase was more marked for PDDs other than
autism but the increase in autism was also striking (table
3). If these changes indicate a true increase in the inci-
dence of the conditions it is of great public health impor-
tance. However, it is probable that the increase is due, at
least in part, to changes in the ascertainment and diagno-
sis of the conditions.
Factors that could have affected the results
Some of the general practices contributing data to the
GPRD will provide anonymised copies of hospital letters
and specialist reports on individual patients. Of patients
with a recorded diagnosis of PDD in the GPRD, including
prevalent cases when first registered, 446 were registered
with 203 general practices willing to provide this service.
For 80 of these, medical records were not available as the
patient was no longer registered with the general practi-
tioner. We obtained complete case records including cop-
ies of hospital clinic letters and specialist reports for 318
(87%) of the remaining 366 people. These were reviewed
by a psychologist (LH) and a random sample of 50
records were also reviewed by a child psychiatrist (EF),
both of whom have long experience in the field of autism.
They judged that a PDD was likely to be present in 294
children (92.5%)[15]. For the 211 patients (of 318) who
were first diagnosed with a PDD after they entered the
GPRD (and thus are included in this paper), a diagnosis
of PDD was confirmed for 193 (91.5%). Thus the positive
predictive value of a recorded diagnosis of PDD in the
electronic record was high, but we were not able to assess
the sensitivity of the ascertainment of cases, that is how
often the diagnosis of a PDD may have been missed or not
recorded.
Of the 211 cases reviewed and included in this paper, 5
(2.4%) were classified as 'other-PDD' on the basis of their
electronic record only, whereas in the validation, 32
(15.1%) met diagnostic criteria for a PDD other than
autism. Thus it is likely that a proportion of people in the
'autism' diagnostic category in this paper have a form of
PDD other than autism. The inaccuracy of diagnostic
descriptions of different PDDs within the GPRD is likely
to reflect changes in the definition of PDD over the past
Table 4: Crude incidence rates (per 10 000 person-years) and age standardised incidence ratios (SIR) for the period 1988 to 2001 by 
geographical area of the United Kingdom (listed in order of SIR)
Autism Other PDDs ALL
Region Number 
of cases
Incidence 
rate
SIR Number 
of cases
Incidence 
rate
SIR Number 
of cases
Incidence 
rate
SIR (95%CI)
WALES 40 0.64 83 1 0.02 7 41 0.65 66 (49,90)
NORTH WEST 121 0.60 78 32 0.16 72 153 0.76 77 (66,90)
NORTHERN & YORKSHIRE 86 0.74 98 11 0.10 43 97 0.84 85 (70,104)
N. IRELAND 29 0.71 97 7 0.17 79 36 0.88 93 (67,129)
EASTERN 132 0.76 97 35 0.20 90 167 0.96 95 (82,111)
SCOTLAND 32 0.62 84 15 0.29 135 47 0.91 96 (72,128)
LONDON 112 0.79 103 24 0.17 78 136 0.96 97 (82,115)
TRENT 94 0.79 100 24 0.20 90 118 0.99 98 (82,117)
SOUTH WEST 99 0.72 92 44 0.32 144 143 1.03 103 (87,121)
WEST MIDLANDS 146 0.85 113 36 0.21 97 182 1.06 109 (94,126)
SOUTH EAST 206 1.00 128 84 0.41 184 290 1.40 141 (126,158)
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two decades, in particular a broadening of PDDs other
than autism [1,16,17]. Many children with Asperger's syn-
drome or pervasive developmental disorder not otherwise
specified would only have been assigned a diagnosis of
PDD from the latter half of the 1990s. In the earlier period
such children may either not have received a diagnosis of
PDD at all or have been diagnosed as autism. Inflation in
the number of cases in later years could have occurred as
other PDD diagnoses came into widespread use and some
previously undiagnosed children were diagnosed. For
example the OXMIS coding dictionary, used by most gen-
eral practitioners contributing to the GPRD until the mid-
1990s, has only two possible codes for autism and no
clinical code for Asperger's syndrome, and this diagnosis
could only be assigned when practices started to use the
READ coding system. These changes explain the low level
of diagnoses of other PDDs until the mid 1990s (table 3).
During the study period there is likely to have been an
increase in the diagnosis of high-functioning autism, as
professionals have become more aware that autism can
occur in people of normal intelligence [3]. Greater ascer-
tainment of high-functioning autism may partly explain
the increased incidence of autism as well as in the other-
PDD diagnoses. That there was also a marked increase in
the rate of diagnosis of severe disorders, however, suggests
that better detection of less severe cases alone can not
explain all of the increase. Two previous studies have
demonstrated falls in the rates of diagnosis of mental
retardation [6] and of non-specific developmental disor-
ders [18] during the 1990s as the rate of diagnosis of
autism increased. These patterns could be partly due to
improvements in the detection and diagnosis of autism.
In the late 1980s and early 1990s autism was only likely
to be diagnosed by specialist child psychiatrists who
increased in number by 40% between 1988 and 2001
(personal communication: Royal College of Psychia-
trists). Through the 1990s developmental and community
paediatricians began to diagnose PDDs, and this, com-
bined with increased awareness of autism and PDDs
among the general public, may have contributed to
increased ascertainment of the disorders [19]. The marked
geographical variation in rates of diagnosis and in the
ratio of diagnoses of autism to other PDDs (table 4) may
reflect differences in service provision and parental aware-
ness in different regions.
It is likely that children with PDDs other than autism will
generally be first diagnosed at later ages than children
with autism. Greater ascertainment of other PDDs during
the latter part of the study period (table 3) could have led
to the observed increase in incidence being largely
restricted to older age groups. However, the increased
rates were observed for all age groups (table 2).
Because of low numbers of cases in some years, indirect
standardisation was used to calculate SIRs. When compar-
ing SIRs, marked differences in the age distribution of the
populations being compared can lead to a biased compar-
ison [20]. However, the differences in age distributions
were not great in our study and the patterns seen in the
crude rates and the age standardised rates did not differ
materially, suggesting the comparison of SIRs was valid.
The accuracy of the denominator data may have changed
during the study period. When patients move geographi-
cal area they may delay registering with a new general
practice until they have a specific reason to visit them.
Thus our estimates of person-years at risk may be too low
for those moving into a practice and too high for those
moving out. Person-years at risk may also be inflated as
patients who emigrate may omit to inform their general
practitioner and, furthermore, administrative delays and
errors may result in individuals being registered with
more than one general practitioner. For example, in 1997
in England 51 million people were registered with a gen-
eral practitioner [21] whereas the total population size
was only around 49 million people[22]. It has also been
suggested that in recent years the period of time for which
patients who have moved out of an area remain registered
with a general practice in that area has shortened as health
authorities and general practices have streamlined proce-
dures [23]. This may mean that the inflation of denomi-
nators could have been greater in the early years compared
to later years. However, these factors could explain only a
very small part of the increased rates observed. An addi-
tional issue is that the person-years used as denominators
in our analysis did not exclude the period following diag-
nosis. However, given the relative rarity of the disease, this
will have produced only a very small inflation in the
denominators.
Comparison with other studies
A previous study based on the GPRD assessed time trends
in the diagnosis of autism from 1988 to 1999 [24,25]. The
study did not examine other PDDs, was restricted to chil-
dren aged less than 13 years and included a total of 305
cases. The previous paper was based on a sub-set of the
GPRD data held by the Boston Collaborative Drug Sur-
veillance Program. This is reflected in the person-years of
observation contributing to the two studies – just under
3.1 million person years in the previous study compared
with over 14 million person years in our paper. The two
studies were undertaken in substantially different popula-
tions. However, the extent of the rise in incidence in the
two studies was similar: from around 0.3/10,000 person-
years in 1989/1990 to around 2.0/10,000 person-years by
1999 [24]. In addition, the increased risks of autism
observed in successive birth cohorts were similar to those
observed in our study [25]. A study in the West Midlands
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area of the United Kingdom based on diagnoses made at
child development centres found cumulative incidence
rates of autism for children between the ages of one to
four years of 2.22/10,000 person-years in 1991–3 (based
on 20 cases), rising to 4.75/10,000 person-years in 1994–
6 (based on 42 cases) [26]. The corresponding cumulative
rates from our study were 1.00/10,000 person-years in
1991–3 rising to 1.97/10,000 person-years for 1994–6.
Restricting our data to the West Midlands region we
observed rates of recorded diagnosis of autism of 1.57/
10,000 person-years in 1991–3 and 1.56/10,000 person-
years in 1994–6, based on 14 and 16 cases respectively. It
is unclear why the rates observed in the West Midlands
study were different from the rates we observed. However,
these area and time period specific rates are based on
small numbers of cases. The validation of cases in the
GPRD can not necessarily be assumed to apply to all geo-
graphical areas. A recent study in North London estimated
the prevalence of autism by year of birth and concluded
there was a rise from 1979 to 1992 after which there was
a plateau between 1992 and 1996 [27]. These authors
excluded children with Asperger's. The review of clinical
records of children in our study indicated that some chil-
dren who would have been diagnosed as having autism in
the early 1990s actually had Asperger's and would
probably not have been classified as 'autism' in later years.
This shift in diagnostic labelling from autism to Asperger's
may explain, at least in part, the plateau in incidence
described by Lingam et al. and would be compatible with
the reduction in average age at diagnosis observed in that
study.
Conclusions
This is one of the largest studies undertaken of trends in
the incidence of autism and other PDDs. We describe
striking increases in the rates of diagnosis of these condi-
tions. However, much of the increase may be due to better
ascertainment related to changes in diagnostic practice
and improved recognition of the conditions. While review
of clinical records confirmed that over 90% of diagnoses
of PDDs recorded by general practitioners were likely to
be correct, the nature of the study precluded us from
assessing how often children with PDDs were not diag-
nosed. Thus the extent to which the increases in incidence
we document are true increases in disease is uncertain.
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